Last reviewed · How we verify
Azithromycin, Minocycline or Doxycycline — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Azithromycin, Minocycline or Doxycycline (Azithromycin, Minocycline or Doxycycline) — Qingfeng Pharmaceutical Group.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Azithromycin, Minocycline or Doxycycline TARGET | Azithromycin, Minocycline or Doxycycline | Qingfeng Pharmaceutical Group | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Azithromycin, Minocycline or Doxycycline CI watch — RSS
- Azithromycin, Minocycline or Doxycycline CI watch — Atom
- Azithromycin, Minocycline or Doxycycline CI watch — JSON
- Azithromycin, Minocycline or Doxycycline alone — RSS
Cite this brief
Drug Landscape (2026). Azithromycin, Minocycline or Doxycycline — Competitive Intelligence Brief. https://druglandscape.com/ci/azithromycin-minocycline-or-doxycycline. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab